World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
10201
World Ranking
3979
National Ranking
350

Giuseppe Del Giudice publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Giuseppe Del Giudice sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 121 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Giuseppe Del Giudice D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Giuseppe Del Giudice sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Giuseppe Del Giudice is affiliated with GlaxoSmithKline in the United Kingdom and contributes to research spanning medicine and engineering. Their work focuses on diverse fields including civil and structural engineering, immunology, epidemiology, atmospheric science, and molecular biology.

The scientist's main topics of research cover water systems and optimization, vaccine coverage and hesitancy, immune responses and vaccinations, immune response and inflammation, pneumonia and respiratory infections, influenza virus research studies, and urban stormwater management solutions.

Recent publications by Giuseppe Del Giudice include:

  • Short-term rainfall forecasting using cumulative precipitation fields from station data: a probabilistic machine learning approach, 2022, Journal of Hydrology
  • Vaccinology in the post−COVID-19 era, 2021, Proceedings of the National Academy of Sciences
  • Vaccination as a preventative measure contributing to immune fitness, 2021, npj Vaccines
  • Propagation of variability in climate projections within urban flood modelling: A multi-purpose impact analysis, 2021, Journal of Hydrology
  • Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM197 conjugate vaccine, 2020, Proceedings of the National Academy of Sciences

Giuseppe Del Giudice frequently collaborates with other researchers. The most common coauthors are Cristiana Di Cristo, Rino Rappuoli, Roberta Padulano, Stefanía P. Bjarnarson, and Auður Anna Aradóttir Pind.

Their work has been published in several academic venues, including:

  • Frontiers in Immunology
  • Water
  • Journal of Hydrology
  • Proceedings of the National Academy of Sciences
  • npj Vaccines

Best Publications

  • Helicobacter pylori virulence and genetic geography.

    Antonello Covacci;John L. Telford;Giuseppe Del Giudice;Julie Parsonnet

  • Correlates of adjuvanticity: A review on adjuvants in licensed vaccines.

    Giuseppe Del Giudice;Rino Rappuoli;Arnaud M. Didierlaurent

  • The how’s and what’s of vaccine reactogenicity

    Caroline Hervé;Béatrice Laupèze;Giuseppe Del Giudice;Arnaud M. Didierlaurent

  • The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor.

    Barbara Satin;Giuseppe Del Giudice;Vittorina Della Bianca;Stefano Dusi

  • Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children

    Steven Black;Uwe Nicolay;Timo Vesikari;Markus Knuf

  • Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity

    Marzia Monica Giuliani;Giuseppe Del Giudice;Valentina Giannelli;Gordon Dougan

  • MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile.

    Audino Podda;Giuseppe Del Giudice

  • Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels

    Grazia Galli;Duccio Medini;Erica Borgogni;Luisanna Zedda

  • Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guérin priming.

    Christy Barrios;Alexander R. Lussow;Jan Van Embden;Ruurd Van Der Zee

  • The Helicobacter pylori neutrophil-activating protein is an iron-binding protein with dodecameric structure.

    Fiorella Tonello;William G. Dundon;Barbara Satin;Maurizio Molinari

  • Structure of the Neutrophil-activating Protein from Helicobacter pylori

    Giuseppe Zanotti;Elena Papinutto;William G. Dundon;Roberto Battistutta

  • Bordetella pertussis Infection in 2-Month-Old Infants Promotes Type 1 T Cell Responses

    Françoise Mascart;Virginie Verscheure;Anne Malfroot;Marc Hainaut

  • An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine.

    Giuseppe Del Giudice;Anne Katrin Hilbert;Roberto Bugarini;Ada Minutello

  • Therapeutic Vaccination against Helicobacter pylori in the Beagle Dog Experimental Model: Safety, Immunogenicity, and Efficacy

    Giacomo Rossi;Paolo Ruggiero;Samuele Peppoloni;Laura Pancotto

  • The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia

    Francesco Tombola;Laura Morbiato;Giuseppe Del Giudice;Rino Rappuoli

  • Human circulating influenza-CD4+ ICOS1+IL-21+ T cells expand after vaccination, exert helper function, and predict antibody responses.

    Fabiana Spensieri;Erica Borgogni;Luisanna Zedda;Monia Bardelli

  • The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines.

    Barbara C Baudner;Marzia M Giuliani;J.Coos Verhoef;Rino Rappuoli

  • The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells

    Pasqualina Montemurro;Hiroaki Nishioka;William G. Dundon;Marina de Bernard

  • Plant polyphenols inhibit VacA, a toxin secreted by the gastric pathogen Helicobacter pylori.

    Francesco Tombola;Silvia Campello;Laura De Luca;Paolo Ruggiero

  • Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging.

    Giuseppe Del Giudice;Jörg J. Goronzy;Beatrix Grubeck-Loebenstein;Paul Henri Lambert

  • Rationally designed strings of promiscuous CD4(+) T cell epitopes provide help to Haemophilus influenzae type b oligosaccharide: a model for new conjugate vaccines.

    Fabiana Falugi;Roberto Petracca;Massimo Mariani;Enrico Luzzi

Frequent Co-Authors

Rino Rappuoli
Rino Rappuoli Imperial College London
Cesare Montecucco
Cesare Montecucco University of Padua
Paul-Henri Lambert
Paul-Henri Lambert University of Geneva
Jacques A. Louis
Jacques A. Louis Institut Pasteur
Peter Malfertheiner
Peter Malfertheiner Otto-von-Guericke University Magdeburg
Ingileif Jonsdottir
Ingileif Jonsdottir deCODE Genetics (Iceland)
Mario Zoratti
Mario Zoratti University of Padua
Emanuele Papini
Emanuele Papini University of Padua
Mariagrazia Pizza
Mariagrazia Pizza Imperial College London
Guido Grandi
Guido Grandi University of Trento

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare careers, especially in advanced nursing roles that intersect with immunological research and patient care. For those considering a transition into nursing from a different field, exploring accelerated BSN programs for non nurses offers a streamlined path to becoming a registered nurse (RN) quickly.

Nurses looking to enter the workforce promptly might consider fastest and easiest LPN programs. These programs provide foundational nursing skills and can lead to specialized roles that require immunological knowledge.

For experienced nurses aiming for greater autonomy and specialized practice, nurse practitioner programs with easy admission offer accelerated and accessible education routes to advanced practice.

Additionally, those interested in mental health's immunological aspects may find top psychiatric mental health nurse practitioner programs online valuable. These programs combine clinical practice with advanced insights into the immune system’s role in psychiatric conditions.

Considering these related degree pathways helps students and professionals align their immunology interests with careers that impact patient outcomes and biomedical innovations.

Best Scientists Citing Giuseppe Del Giudice

Trending Scientists

Recently Published Articles